|
|
Volumn 320, Issue 7246, 2000, Pages 1357-
|
|
Drug companies cut HIV drug prices in the developing world.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
DRUG;
ACQUIRED IMMUNODEFICIENCY SYNDROME--PREVENTION AND CONTROL;
ARTICLE;
COST;
DEVELOPING COUNTRY;
DISEASES;
DRUG INDUSTRY;
ECONOMIC FACTORS;
ECONOMICS;
HIV INFECTIONS--PREVENTION AND CONTROL;
HUMAN;
MARKETING;
PRICING;
TREATMENT;
VIRAL DISEASES;
ACQUIRED IMMUNODEFICIENCY SYNDROME--PREVENTION AND CONTROL;
DEVELOPING COUNTRIES;
DISEASES;
DRUGS;
ECONOMIC FACTORS;
HIV INFECTIONS--PREVENTION AND CONTROL;
MARKETING;
PRICING;
TREATMENT;
VIRAL DISEASES;
ANTI-HIV AGENTS;
COSTS AND COST ANALYSIS;
DEVELOPING COUNTRIES;
DRUG INDUSTRY;
HUMANS;
|
|
EID: 0034690509
PISSN: 09598138
EISSN: None
Source Type: Journal
DOI: 10.1136/bmj.320.7246.1357 Document Type: Article |
|
Times cited : (8)
|
|
References (0)
|
